This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lansdale, PA (US) (2001)
- Audubon, PA (US) (2002)
Company Filing History:
Years Active: 2001-2002
Title: Ruth Rutledge: Innovator in Angiogenesis Inhibition
Introduction
Ruth Rutledge is a notable inventor based in Audubon, PA (US). She has made significant contributions to the field of medical research, particularly in the development of angiogenesis inhibitors. With a total of 2 patents, her work focuses on innovative solutions for treating various diseases.
Latest Patents
Ruth's latest patents revolve around compounds that inhibit tyrosine kinase enzymes. These inventions include compositions that contain tyrosine kinase inhibiting compounds and methods for using these inhibitors to treat tyrosine kinase-dependent diseases and conditions. Such conditions include angiogenesis, cancer, atherosclerosis, diabetic retinopathy, and autoimmune diseases in mammals.
Career Highlights
Ruth Rutledge is currently associated with Merck & Co., Inc., where she continues to advance her research and development efforts. Her work has the potential to impact the treatment of serious health conditions, showcasing her dedication to improving patient outcomes.
Collaborations
Ruth has collaborated with esteemed colleagues, including Mark T Bilodeau and Randall W Hungate. These partnerships enhance her research capabilities and contribute to the innovative environment at Merck.
Conclusion
Ruth Rutledge stands out as a pioneering inventor in the field of angiogenesis inhibitors. Her contributions are vital in the ongoing fight against various diseases, and her work continues to inspire advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile